Though skin fibroblasts (FB) are the main cell population within the dermis, the different skin FB subsets are not well characterized and the traditional classification into reticular and papillary FBs has little functional relevance. To fill the gap of knowledge on FB diversity in human skin, we performed single-cell RNA sequencing. Investigation of marker genes for the different skin cell subtypes revealed a heterogeneous picture of FBs. When mapping reticular and papillary FB markers, we could not detect cluster specificity, suggesting that these two populations show a higher transcriptional heterogeneity than expected. This finding was further confirmed by in situ hybridization, showing that DPP4 was expressed in both dermal layers. Our analysis identified six FB clusters with distinct transcriptional signatures.
Abstract
Though skin fibroblasts (FB) are the main cell population within the dermis, the different skin FB subsets are not well characterized and the traditional classification into reticular and papillary FBs has little functional relevance. To fill the gap of knowledge on FB diversity in human skin, we performed single-cell RNA sequencing. Investigation of marker genes for the different skin cell subtypes revealed a heterogeneous picture of FBs. When mapping reticular and papillary FB markers, we could not detect cluster specificity, suggesting that these two populations show a higher transcriptional heterogeneity than expected. This finding was further confirmed by in situ hybridization, showing that DPP4 was expressed in both dermal layers. Our analysis identified six FB clusters with distinct transcriptional signatures.
Importantly, we could demonstrate that in human skin DPP4 + FBs are the main producers of factors involved in extracellular matrix (ECM) assembly. In conclusion, we provide evidence that hitherto considered FB markers are not ideal to characterize skin FB subpopulations in single-cell sequencing analyses. The identification of DPP4 + FBs as the main ECM-producing cells in human skin will foster the development of anti-fibrotic treatments for the skin and other organs.
| INTRODUCTION
In the past, dermal fibroblasts (FBs) had been considered to play a rather marginal role with the exclusive responsibility of producing components of the extracellular matrix (ECM), such as collagens and elastin. 1 In recent years, however, FBs have gained increasing attention as their involvement in matrix remodeling during wound healing and scar formation, cancer invasion, 2 and skin aging has been discovered. 3, 4 Based on their anatomical localization in the skin, two distinct populations of dermal FBs with different shape and function, that is, papillary and reticular FBs, have been identified. 1, [5] [6] [7] [8] [9] [10] While the papillary dermis (uppermost 300 µm) displays high cell density, the reticular dermis is characterized by a dense ECM network and rather low cell density. 5 The majority of previous studies have investigated their functions in vitro, which strongly affects phenotype and function of FBs. 11 Recently, other strategies have been employed to decipher the roles of papillary and reticular FBs. For instance, Korosec et al have used a dermatome to mechanically separate papillary and reticular dermis and characterized the major FB population in each dermal layer by the expression levels of Thy-1 cell surface antigen (THY1) and fibroblast activation protein-alpha (FAP). 12 Although the so defined populations show all characteristics of either papillary or reticular FBs, their appearance is not strictly limited to the respective skin layer. Furthermore, they showed that the location within the dermis affects the expression of various enzymes and likely also their function. A study by Tabib and colleagues suggests a more diverse picture than initially expected. 13 Their work revealed, next to several smaller FB populations, the presence of two major FB populations in human skin, which do not coincide with their location in either the papillary or reticular dermis. 13 Together, recent literature on skin FBs suggests FB heterogeneity in the skin, and a sole classification of skin FBs based on the anatomical localization into papillary and reticular FBs might not be sufficient to fully understand their specific roles in skin homeostasis and tissue regeneration after injury.
So far, several markers have been suggested to discriminate between papillary and reticular FBs, including podoplanin (PDPN), netrin-1 (NTN1), matrix Gla protein (MGP), 1, 5, 8 and dipeptidyl peptidase 4 (DPP4). 12 DPP4 is an enzyme which cleaves a broad range of substrates, including chemokines and vasoactive peptides. 14 While DPP4 was previously found in mouse papillary dermis during embryonic and early postnatal development, in adult mice DPP4 expression was mainly located in the reticular dermis. 15, 16 In contrast, Korosec et al have recently demonstrated that DPP4 + FBs in human skin are mainly located in the papillary dermis, but also detectable at lower levels in the reticular dermis. 12 In addition, Tabib et al 13 show DPP4 expression in FBs of both dermal layers in human skin, and suggest a novel major FB population characterized by co-expression of DPP4 and secreted frizzled related protein 2 (SFRP2), a soluble modulator of Wnt signaling. 17, 18 However, most of the relevant literature on the role of DPP4-expressing skin fibroblasts still originates from mouse studies. Rinkevich et al demonstrated that a distinct DPP4-expressing lineage of FBs in the mouse skin was responsible for elevated ECM deposition and fibrosis during scar formation. 19 Interestingly, inhibition of DPP4 activity results in attenuated matrix secretion and reduced transforming growth factor beta 1 (TGFB1)-mediated pro-fibrotic effects, indicating a prominent role of DPP4 in wound healing and scar formation. 20, 21 In contrast to mouse studies, reports on the expression and the properties of DPP4 in human skin are scarce and inconsistent, 12, 13, [22] [23] [24] [25] [26] complicating clinical translation of these findings. Moreover, the existence of a DPP4 + FB subset responsible for the production of the ECM has not been confirmed in human skin so far.
In the present study, we sought to investigate the functional heterogeneity of human skin FBs in a setting mimicking the in vivo situation using single-cell RNA sequencing. Considering the presumptive, yet elusive role of DPP4 in wound healing and scar formation, we delineated the complex diversity of FB populations in human skin and characterized the DPP4-expressing FB subpopulation in detail.
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| Single-cell RNA sequencing (scRNAseq)
Immediately after cell sorting, the single-cell suspension was processed for single-cell separation and cDNA library preparation. For generation of Gel Bead-in Emulsion (GEMs), the 10X Genomics Chromium instrument (Singlecell gene expression 3′v2, 10X Genomics, Pleasanton, CA, USA) was used. Processing of the single-cell suspension to a GEM emulsion, library preparation, and RNA sequencing were performed by the Biomedical Sequencing Core Facility of the Center for Molecular Medicine (Center for Molecular Medicine, Vienna, Austria). Obtaining biopsies and acquiring cell suspensions by Chromium instrument occurred within 3.5 hours. In total, data from ~5000 cells were isolated. Sequencing was performed using Illumina HiSeq 3000/4000 (Illumina, San Diego, CA, USA).
| Data analysis
Raw sequencing data from all samples were demultiplexed and aligned to a reference genome (GrCh38) using the CellRanger Fastq pipeline by 10X Genomics. In the fastq-files generated by the fastq-pipeline, cell barcodes, and unique molecular identifiers (UMIs) were counted using the Cellranger Count pipeline to generate a gene-barcode matrix. To compare the three donor datasets, the gene-barcode matrices were loaded into Seurat individually, integrated with the recommended standard workflow, and tested for their donor variations (Data not shown). Ultimately, the samples were aggregated in the Cellranger Aggregate pipeline, yielding a single gene-barcode matrix of all cells as the basis for secondary analysis.
For secondary analysis, the R-package "Seurat" was used (Seurat v2, Satija Lab, NYU, New York, USA) 27, 28 with R-Studio software in R (The R Foundation, Vienna, Austria). 29 To remove unwanted variations in the scRNAseq data, cells were first analyzed for their UMI and mitochondrial gene counts, and cells with low or very high UMI count or high percentage of mitochondrial genes were excluded from the data set. Data were scaled 30 and principal component analysis (PCA) was performed. Statistically significant principal components (PCs) were identified by visual inspection and by using the JackStraw Procedure. 31 Based on significant PCs, clusters were identified using the Louvain algorithm at a resolution of 1.2 and 10 iterations. The preselected PCs and identified clusters served as the basis for t-stochastic neighbor embedding (tSNE), which visually clusters cells in an unsupervised manner according to the similarity of their PCA signature. To identify significant changes in expressed genes in DPP4 + versus DPP4 − FB, all cells assigned to "FB-clusters were grouped together, and cells with DPP4-log2 fold change higher than 0.5 (scaled data compared to the entire data set) were defined as "DPP4 + ". Differentially expressed genes in all DPP4 + versus DPP4 − FBs in multivariate testing were calculated using the Wilcoxon rank sum test. Adjusted P value was calculated by Bonferroni correction based on the total number of genes in the dataset. To confirm statistical significance, an implementation of the Student's t-test was employed for each gene of interest in all DPP4 + versus DPP4 − cells.
| GO-term analysis and functional network analysis
For functional analysis of differentially expressed genes, gene lists were filtered for significance with adjusted P values <.05 (adjusted by Bonferroni correction), and log2 expression fold changes >0.25. Filtered lists were then submitted to ClueGO-tool 32 in Cytoscape, 33 and GO-term analysis for biological processes, immune system processes, and molecular functions were included in the calculation. The analysis was calculated with medium network specificity, GO-term fusion was applied and only pathways with P values of <.05 were calculated and visualized in the resulting network.
| Pseudotime and trajectory analysis
To calculate pseudotime values and trajectories, the 'Seurat' object was converted to a CellDataSet and loaded into Monocle2. 34 Size factors and dispersions were estimated, outliers removed, and clustering was performed after tSNE-reduction. As model formula input for trajectory construction, differentially expressed genes between FB clusters were used, and trajectories were constructed with DDRTree. Branched expression analysis model (BEAM) 35 was applied to the branching point, and genes with q-value 10 −30 were displayed in the heatmap.
| Isolation of skin cell subsets for affymetrix chip analysis
Cells were isolated from abdominal skin as described previously. 36 Briefly, epidermis and dermis were separated by incubation with Dispase II (2,4 U/mL; Roche Diagnostics GmbH, Mannheim, Germany) for 18 hours at 4°C. KC, LC, and MC were separated from the epidermis by incubation with Trypsin-EDTA (0.05%; Gibco by Life Technologies, Carlsbad, CA, USA) and DNAse I (BD Biosystems) for 30 minutes at 37°C. A suspension of dermal cells was prepared by incubation of the tissue with Liberase Research Grade (400 μg/mL, Roche Diagnostics GmbH, Mannheim, Germany) and DNAse I for 3 hours at 37°C. Different subtypes of skin cells were purified by subsequent incubation with the following MicroBeads: CD1a MicroBeads, CD117 MicroBeads, CD2 MicroBeads, and CD31 MicroBeads. All MicroBeads were obtained from Miltenyi Biotec. Cells were separated on the autoMACS Pro Separator according to the manufacturer's protocols. FB were obtained as a negative fraction after removal of other cell types, including mast cells, schwann cells, T-cells, and endothelial cells from the suspension of dermal cells.
| Affymetrix gene chip analysis
Total RNA was extracted from the purified cell samples using peqGOLD TriFast (VWR International, Radnor, PA, USA) according to the manufacturer's instructions. Transcriptome analysis was performed at the Core Facility Genomics of the Medical University of Vienna, Austria, using Affymetrix Human Gene 2.1 ST Array (Thermo Fisher, Santa Clara, CA, USA).
| Venn diagram
A Venn diagram was constructed using the InteractiVenn browser tool. 37 Differentially expressed genes of each FB cluster compared to the rest of the FBs with log fold change >0.25 and adjusted P value <.05 were used.
| Immunofluorescence staining
Immunofluorescent staining of DPP4 was performed in normal human skin using samples of healthy human surplus skin obtained from plastic surgeries (usage approved by ethics committee Medical University of Vienna Vote Nr 1149/2011). Samples were fixed in formalin and embedded in paraffin, or frozen in OCT compound using liquid nitrogen for cryosections. Sections of 5 µm thickness were used for immunostaining according to protocol as described 38 with primary and secondary antibodies used as listed in Tables S1 and S2. All staining experiments were performed with mouse or rabbit IgG as negative control. Blocking experiments were done using full-length human DPP4 protein (ab79138, Abcam, Cambridge, USA). Images were acquired by AX70 microscope (Olympus, Hamburg, Germany) using the imaging software MetaMorph (Olympus).
| RNAScope In situ hybridization
Healthy human skin was formalin fixed and paraffin embedded (FFPE) for RNAScope In Situ Hybridization (Advanced Cell Diagnostics by biotechne, Minneapolis, USA) according to the manufacturer's pretreatment protocol for FFPE samples. 39 Samples were hybridized with RNAscope probe Hs-DPP4-CDS-XMm, and signals were visualized by RNAscope 2.5 HD Assay-RED, and counterstained with hematoxylin for 10 seconds. Images were acquired as described above.
| Magnetic-activated cell sorting of DPP4 + and DPP4 − fibroblasts
To isolate DPP4 + FB, we dissociated full-thickness skin biopsies with MACS Whole Skin Dissociation Kit as described above. Cell suspensions were incubated with rabbitanti-human-DPP4 antibodies (see Table S1 ) for 30 minutes at 4°C, washed twice, and incubated with magnetic beadlabeled anti-rabbit antibodies (Table S2) for 30 minutes at 4°C. Cells were washed twice, loaded into an AutoMACSdevice (Miltenyi,Biotech), and DPP4 + and DPP4 − cell populations were separated with the "possel"-program provided by the manufacturer. Both cell fractions were seeded into six-well plates and cultured in DMEM with 10% heat-inactivated fetal bovine serum and 1% penicillin/streptomycin. Supernatants were stored at −80°C, and cells were lysed in 1x Laemmli Buffer (Bio-Rad, Hercules, USA) for western blotting.
| Western blot analysis
Lysates from DPP4 + and DPP4 − FB were separated by SDS-PAGE using 4%-15% gradient gels (Bio-Rad). Proteins were transferred onto nitrocellulose membranes (Bio-Rad), blocked with non-fat dry milk, and incubated with primary antibodies (Table S1 ) overnight at 4°C. Membranes were washed 3 times and incubated with horseradish peroxidaseconjugated secondary antibody (Table S2) for 30 minutes at room temperature. Signals were visualized with SuperSignal West Dura Extended Duration Substrate (ThermoFisher Scientific) and detected by a ChemiDoc XRS+ (Bio-Rad).
| Enyzme-linked Immunosorbent Assay (ELISA)
Human pro-collagen Ia1 ELISA (R&D Systems, Biotechne, Minneapolis, USA) and human fibronectin ELISA (R&D Systems) were performed in duplicates using supernatants obtained from cultured DPP4 + and DPP4 − FBs according to the manufacturer's manual. For collagen Ia1 and fibronectin, samples were diluted 1:100 and 1:10, respectively. Absorbance was detected by FluoStar Optima microplate reader (BMG Labtech, Ortenberg, Germany).
| RESULTS

| scRNAseq identifies six transcriptionally distinct FB populations in healthy human skin
To obtain detailed information on FB populations in healthy human skin, we performed scRNAseq of three healthy
donors. After t-SNE-clustering based on principal component analysis, we were able to discriminate between 18 different cell populations in the human skin, including T-cells (TC), dendritic cells (DC), macrophages (Mac), Langerhans cells (LC), mast cells (MC), endothelial cells (EC), lymphatic EC (LEC), pericytes (PC), smooth muscle cells (SMC), four distinct keratinocyte (KC), and six different FB populations ( Figure 1A ). All clusters were confirmed by visualization of marker gene expressions ( Figure 1B ) and showed distinct transcriptional patterns when displayed in a heatmap ( Figure  S1A,B) . Separate analysis of all three donors revealed presence of all clusters and comparable cluster marker gene expression in each donor with only minor differences observed in cell numbers (data not shown). Identification of FB clusters by commonly used FB markers, such as vimentin (VIM), S100 calcium binding protein A4 (S100A4) or fibrillin 1 (FBN1) failed, as they were either also detected in several other cell clusters or did not cover all FB subsets ( Figure S2 ). To identify genes that specifically mark the respective FB clusters, we compared the transcriptome of the FB clusters to that of all other cells and screened the resulting gene list for reliable new candidates. Interestingly, we found several marker genes, encoding cytoplasmic [fibulin-1 (FBLN1), lumican (LUM), and procollagen C-endopeptidase enhancer (PCOLCE) Figure 1C -E] and transmembrane proteins [phospholipid phosphatase 3 (PLPP3), syndecan 2 (SDC2), and matrix remodeling associated 8 (MXRA8) ( Figure 1F -H)] that were expressed by all FB clusters. LUM and MXRA8 showed the most FB-specific expression pattern. Comparison of all subsets in a Venn diagram identified serpin family G member 1 (SERPING1) as the only gene strongly expressed in all six subpopulations ( Figure S3 ). However, its expression was not confined to FBs, since it was also detected in pericytes, smooth muscle cells, and endothelial cells. To further investigate this, we used an alternative method and enriched different skin cell populations using magnetic beads. As shown in Figure S4 , we found expression of LUM, PCOLCE, SDC2, and MXRA8 specifically in FBs, confirming the specificity of these markers.
| scRNAseq does not mirror identities of papillary and reticular FB
As FBs have been described to show phenotypic heterogeneity, gene expression, and ability to synthesize ECM, 5, 6, 13, 40 we next wanted to compare the transcriptomes of every identified FB cluster (Data will be made available upon request). Interestingly, this comparison did not reveal the classical discrimination of papillary and reticular FBs, since markers for these FB subsets, such as netrin 1 (NTN1), podoplanin (PDPN), and matrix Gla protein (MGP), 5, 12, 41 were detected in all FB clusters ( Figure S5 ). We also screened our data set for genes which have recently been shown to identify major FB subsets in the skin, such as THY1, FAP, secreted frizzledrelated protein 2 (SFRP2), and flavin containing monooxygenase 1 (FMO1). 12, 42, 43 Remarkably, THY1 (Figure 2A) , FAP ( Figure 2B ), and FMO1 ( Figure 2C ) showed only marginal expression in our dataset (15,4% THY1 + , 16,3% FAP + , and 3% FMO1 + FB). By contrast, SFRP2 expression was detected in 60% of all FBs ( Figure 2D ). These data indicate that, in contrast to identification of FB subsets by marker protein expression, other, strongly expressed marker genes are necessary to properly identify FB subsets in single-cell sequencing analyses. Our analysis identified several other genes, including microfibril-associated protein 5 (MFAP5), apolipoprotein E (APOE), APC down-regulated 1 (APCDD1), beta-1,4-galactosyltransferase 1 (BGALT1), C-X-C motif chemokine ligand 1 (CXCL1), and WNT inhibitory factor 1 (WIF1), as most suitable to discriminate between the different FB clusters present in human skin (Figure 2E-J) . Although we observed a clear discrimination of FB1 ( Figure  2E ) and FB4 ( Figure 2H ), the clusters FB2 ( Figure 2F ), FB3 ( Figure 2G ), FB5 ( Figure 2I ), and FB6 ( Figure 2J) were not clearly distinguishable from each other on the RNA level, suggesting a high transcriptional similarity.
| FB clusters are functionally heterogeneous
To bioinformatically investigate possible functional differences between the six FB clusters, we performed GO-term analysis using the network visualization and clustering tool ClueGO [25] , a Cytoscape plugin [26] . Networks of functionally clustered GO-term groups were generated using genes significantly enriched in each FB cluster. As shown in Figure 3 and Supporting Information Figures S6-S11, we indeed detected significant functional differences. We found strong associations of FB1 with ECM assembly ( Figure 3A,B) , wound healing ( Figure 3C ), and angiogenesis ( Figure 3D and Figure S6 ). FB2 and FB5 were mainly associated with immunological processes, including antimicrobial immune response ( Figure 3E ) and leukocyte migration ( Figures 3F, S7 and S10). By contrast, FB3 showed a very specific association with cartilage development ( Figure 3G ) and leptin signaling ( Figures 3H  and S8 ). FB4 was mainly characterized by its response to growth factors ( Figures 3I and S9) , whereas FB6 was distinguished by its association with interferon-gamma (IFNG) response and p38 and NFκB signaling ( Figures 3J-l, S11 ). Together, our analysis identified six dermal FB subsets which differ significantly from each other with regard to their putative functional properties. Since one of the main functions of FB is the production and assembly of the ECM, to confirm our findings obtained by GO-term enrichment analysis, 1, 5 we investigated this particular process in more detail 
F I G U R E 2 Differential gene expression analysis reveals specific genes distinguishing FB clusters. A,B, Feature plots and violin plots of
previously described FB marker genes, Thy-1 cell surface antigen (THY1), and fibroblast activation protein alpha (FAP). C,D, Feature plots and violin plots of previously described FB clustering genes, Flavin-containing monooxygenase 1 (FMO1), and secreted frizzled-related protein 2 (SFRP2). E-J, Feature plots and violin plots of genes characterizing each FB cluster. Microfibril-associated protein 5 (MFAP5), apolipoprotein E (APOE), APC downregulated 1 (APCDD1), beta-1,4-galactosyltransferase 1 (B4GALT1), C-X-C motif chemokine ligand 1 (CXCL1), and WNT inhibitory factor 1 (WIF1). In violin plots, dots represent individual cells. y-axis represents log2 fold change of the normalized genes and log-transformed single-cell expression. Vertical lines in violin plots represent maximum expression, shape of each violin represents all results, and width of each violin represents frequency of respective expression level. In feature plots, expression of the respective gene is mapped onto the tSNE-plot. Color intensity indicates level of gene expressions. tSNE, t-stochastic neighbor embedding by analyzing the expression of components of the ECM and factors important for ECM remodeling in all human FB populations. Interestingly, most of the ECM-related genes investigated showed highest expression levels in FB1 (Figure 4) .
Strikingly, among the highest differentially expressed mRNAs, we found many components of the ECM, including the collagens COL1A1, COL1A2, COL3A1, COL12A1, as well as elastin (ELN), fibronectin (FN1), and fibrillin (FBN1). We also found overexpression of several factors involved in matrix assembly, such as MFAP4 and MFAP5, SFRP2, lysyl oxidase (LOX), hyaluronan synthase 1 (HAS1), FAP, and annexin A2 (ANXA2). Interestingly, factors involved in matrix remodeling, such as matrix metallopeptidases (MMP2, MMP14), as well as the TIMP metallopeptidase inhibitors (TIMP1, TIMP2, TIMP3) were not specifically expressed in FB1. Some of the investigated factors, such as COL14A1, FN1, HAS1, and MMP14 were either specifically expressed in FB cluster 6 or in both FB clusters 1 and 6, suggesting a contribution of FB cluster 6 to matrix assembly (Figure 4 ).
| Functional clustering of DPP4 + FB reveals a role in ECM assembly, tissue regeneration, and immune defense
Since DPP4 + FBs were identified as the culprits of ECM deposition and fibrotic scar formation in mice, 19 we next sought to confirm their presence in human skin and closely investigate their properties. Our single-cell sequencing dataset revealed highest expression of DPP4 in FB1 ( Figures 5A,B and S12) . In contrast, only minute DPP4 positivity was detected in other FB clusters, T-cells, dendritic
F I G U R E 4 ECM-related gene expression differs among FB clusters. Violin plots of genes associated with ECM formation and ECM
assembly in all FB clusters. Genes were selected according to GO-terms of ECM-secretion/formation/assembly. Collagens (COL1A1,COL1A2, COL3A1, COL12A1, and COL14A1), elastin (ELN), fibronectin (FN1), fibrillin (FBN1), microfibril-associated proteins 4 and 5 (MFAP4 and MFAP5), secreted frizzled-related protein 2 (SFRP2), lysyloxygenase (LOX), hyaluronan synthase 1 (HAS), fibroblast activation protein alpha (FAP), annexin 2 (ANXA2), matrix metallopeptidases 2 and 4 (MMP2 and MMP14), tissue inhibitor of metalloproteases 1, 2, and 3 (TIMP1, TIMP2, and TIMP3). In violin plots, dots represent individual cells. y-axis represents log2 fold change of the normalized genes and logtransformed single-cell expression. Vertical lines in violin plots represent maximum expression, shape of each violin represents all results, and width of each violin represents frequency of respective expression level. Color code indicates FB subpopulations cells, and lymphatic endothelial cells (Figure 5A,B) . When analyzing co-expression of DPP4 with traditional gene markers for FB of the papillary and reticular dermis, we detected DPP4 + FBs in both subsets, suggesting that a clear assignment of DPP4 + FBs to either of the two dermal compartments in the human skin, as suggested previously in mouse skin, 15, 16 is not possible on the transcriptional level ( Figure 5C-E) . Since data on DPP4 expression in the skin are controversial 24, 34 and to confirm our findings of DPP4 + FBs on protein level, we next investigated DPP4 protein expression in human skin by immunofluorescence staining. Strikingly, all antibodies used showed different expression patterns ( Figure S13 ). While antibody #1 exclusively stained tryptase-positive mast cells ( Figure S13A ) and antibodies #2 and #3 showed only diffuse staining of KCs ( Figure  S13B,C) , antibody #4 revealed strong staining in all FBs. Antibody #5 showed DPP4-positivity in mast cells, blood vessels and melanocytes ( Figure S13E ), and antibody #6 in mast cells and FBs. Together, our analysis shows that detection of DPP4 in human skin is difficult and results should be interpreted with caution. Since immunostaining was not reliable, we wanted to verify our data by assessing localization of DPP4 mRNA expression in healthy human skin by in situ hybridization using RNAScope. As shown in Figure 5 , DPP4 + FBs were found in both papillary ( Figure 5F ) and reticular dermis ( Figure 5G ), confirming our single-cell sequencing data.
We next analyzed expression of the ECM-related factors shown in Figure 4 in the DPP4 + FBs and found that, in comparison to DPP − FBs, all genes were significantly upregulated in the DPP4 + FB, corroborating the role of DPP4 + FB in matrix assembly ( Figure 6A ). To further characterize DPP4 + FBs, we performed GO-term analysis ( Figure  6B ). Besides the expected association of DPP4 + FBs with ECM formation and the pool of active proteases in the skin, our bioinformatics analysis revealed a possible functional involvement of DPP4 + FBs in tissue regeneration and immunological processes. Interestingly, our data suggest an antiproliferative, yet cell migration-favoring role of DPP4 + FBs. Furthermore, we identified a potential contribution of DPP4 + FBs to blood vessel formation and blood coagulation, two events involved in wound healing. Our analysis also suggests a role for DPP4 + FBs in immune defense by affecting leucocyte activation and neutrophil degranulation. In contrast to DPP4 + FBs, DPP4 − FBs were mainly associated with the p38/MAPK and NFκB-pathway, suggesting a role in response to growth and inflammatory stimuli ( Figure S14 ). To corroborate our bioinformatics result of ECM overproduction by DPP4 + FBs, we isolated DPP4 + and DPP4 − FBs from three different donors and analyzed the expression of the ECM-proteins collagen Ia1 and fibronectin by ELISA. Of note, also initially DPP4 − FBs expressed low levels of DPP4 after cultivation for several days (Figure 6C ), suggesting a positive regulation of DPP4 expression in cultivated FBs. Our analyses revealed a significantly enhanced production of collagen Ia1 and a trend for increased fibronectin production in DPP4 + FBs compared to DPP4 − FBs (Figure 6D ), indicating the DPP4 + FB population as the main producer of ECM components in humans.
| Pseudotime ordering and trajectory construction reveals two possible FB cell fates
To obtain more information on FB cell fates, differentiation, and temporal gene expression changes, we performed pseudotime trajectory analysis by submitting our data set to Monocle2, and constructing a trajectory ( Figure 7A ) based on pseudotime-sorted cells ( Figure 7B ). This analysis revealed one branching point splitting FB populations into two directions. Interestingly, FB4 was located at the beginning of the trajectory, suggesting that FB4 is the least differentiated FB population. Conversely, FB5 was located at the end of branch 1, and FB1 at the end of branch 2 (Figure 7A,B) . As expected, DPP4 expression was more prominent in branch 2, and increased over pseudotime ( Figure 7C ). FB clusters 2, 3, and 6 were distributed equally along all branches. Subsequently, BEAM 35 identified the most significant pseudotime-dependent genes in the trajectory branches, and assembled them in five gene groups ( Figure 7D ). While group 1 is defined by high pseudotime-dependent expression of the respective gene at the beginning of the prebranch and at the end of branch 1, group 2 shows high expression at the end of branch 2 only. In contrast, gene groups 3, 4, and 5 show highest expression at the end of branch 2, with gene group 4 additionally at the beginning of the prebranch. As expected, DPP4-and ECM-related genes were pseudotime dependently expressed at the end of branch 2. Interestingly, we identified several other genes similarly regulated that have been described in skin scarring or organ fibrosis, such as ASPN1 (Asporin), 44 PDGFR (platelet-derived growth factor receptor), 45 CTHRC1 (collagen triple helix repeat containing 1), 46 AEBP1 (adipocyte enhancer-binding protein 1), 47 and TPM1 (Tropomysin 1), 48 further underpinning the fibrogenic properties of FB1.
| DISCUSSION
Although recent studies on dermal FB populations in the skin have already shed some light on their heterogeneity, little is known about the functional differences of these subpopulations. In the present study, we therefore investigated FB subpopulations and their biological properties in healthy human skin. Using single-cell sequencing, we identified three large FB clusters, one of which can be further subdivided into four smaller clusters (FB2, FB3, FB5, FB6), depicting a far more complex picture of skin FB subpopulations beyond the traditional subsets of papillary and reticular FB. 1, 5, 9, 10 Our attempt to identify genes that specifically define all FB populations in single-cell analysis indicated that wellrecognized FB markers, such as VIM, S100A4, THY1, or FAP [1, 5, 11, 26, 40] , are not ideal for this type of analysis, since expression was either not confined to all FB subsets or present in too many other cell types. By contrast, other genes, including SERPING1, FBLN1, PLPP3, LUM, SDC2, PCOLCE, and MXRA8 reliably identified all FB subpopulations. Interestingly, some of these genes (PCOLCE, PLPP3, SDC2, SERPING1) were also found in the pericyte and smooth muscle cell clusters, confirming their high genetic similarity, due to their common mesenchymal progenitor cells. 49 The membrane-associated factors (PLPP3, SDC2, MXRA8) identified in our study are of special interest, since they could be used to solve a common problem observed in tissue cultures. Purified cell types of enzymatically digested organs are often contaminated with FBs. 50, 51 The newly identified membrane-associated FB markers might represent a novel tool to specifically label and remove unwanted FBs from isolated primary cell suspensions. The feasibility of such an approach merits further investigations.
Recent work by Tabib et al already suggested a higher heterogeneity of dermal FBs than previously expected. 12 Although our study revealed some similarities with their work, we found major differences between our and their analyses. Tabib et al suggested SFRP2 and FMO1 as marker genes identifying the two major subset of human skin FBs. By contrast, our analysis showed virtually no expression of FMO1 in any cell and SFRP2 expression in almost every FB subset. When analyzing our data set together with that published by Tabib et al using the same settings, the two data sets differed substantially from each other, which could be due to technical reasons, such as different cell numbers or different RNA reads per cell (data not shown). In contrast to the six FB clusters identified in our data set, the dataset by Tabib et al only revealed four different FB subsets. Since site-specific differences in FBs have been described before, 52-54 a further F I G U R E 7 Pseudotime ordering and trajectory construction reveal two FB cell fates. A, Trajectory plot of all FBs, color coded by FB clusters 1-6. Lower left corner is the beginning of pseudotime, as indicated in the legend. B, Binplot of FBs across pseudotime. x-axis represents pseudotime, y-axis represents percentage of cells in respective pseudotime bin. C, Trajectory plot of DPP4 expression. D, BEAM expression of pseudotime-dependent genes in trajectory branches. Colors represent q-value possible explanation for the observed differences could be that we performed our analyses on abdominal skin, while Tabib et al analyzed sun-exposed skin from the dorsal forearm. In contrast to Tabib et al, who had a more heterogeneous donor cohort (three females and three males; 23-66 years old) at their disposal, we focused on Caucasian female donors younger than 45 years. More studies are needed to fully address the gender-specific and ethnological differences contributing to data variability.
Until now, skin FBs have been characterized as papillary and reticular FB. 5, 8, 10, 12 Our analysis suggests a novel classification of dermal FB subsets, not solely due to their anatomical location within the skin, but, more importantly, based on their transcriptional signature. Interestingly, our newly identified FB subsets do not overlay with common markers used to identify papillary and reticular FBs, suggesting that FBs with similar functions are distributed over all dermal layers. We identified six FB subsets, each characterized by specific putative biological functions. As shown by our marker gene identification, FB2, FB5, and FB6 showed high similarities on the transcriptional level. Intriguingly, a high similarity of FB2 and FB5 was also observed on the functional level, making a clear distinction difficult. Our GO-term analysis revealed a strong association of these two clusters with leucocyte migration and innate immune defense. Cluster 6, however, showed unique biological functions, including p38/MAPK signaling, response to TNFα and IFNγ as well as response to starvation and hypoxia. In contrast, our analysis suggests a very specific role for FB3 in tissue regeneration. This cluster is mainly characterized by its response to leptin (LEP), which was also identified as one of the main functions of FB6. LEP is a proteohormone secreted by white adipocytes, targeting the hypothalamus and thereby regulating the energy balance of the body. 55, 56 Interestingly, our transcriptome analysis revealed that FB3 and FB6 highly and FB1 to a minor degree express the LEP-receptor (LEPR, Figure S15 ). Since application of LEP on mouse wounds has been shown to promote wound healing, 57, 58 and blocking of LEP delays wound healing, 57 our data suggest a contribution of FB3 and FB6 to wound healing in response to LEP.
In contrast to FB2, 3, 5, and 6, FB1 and FB4 displayed the most distinct transcriptomes. While FB4 are functionally associated with response to growth factors, epithelial cell proliferation, and cell morphogenesis, FB1 represents FBs mainly involved in the production and assembly of the ECM. Interestingly, our pseudotime trajectory analysis identified FB4 as the least differentiated and FB1 as one of the more terminally differentiated FB cluster, explaining the vast transcriptional differences. Our analysis suggests a particular function of these FB clusters in wound healing and scar formation. Since DPP4 + FBs have been shown to be responsible for augmented ECM production and fibrosis in mice, 15, 19, 20, 59 we searched for the DPP4 + FB population in our data set and found that DPP4 expression was almost exclusively restricted to FB1. To the best of our knowledge, our analysis is the first to show that DPP4 + FBs are the main producers of factors involved in ECM assembly in human skin. We hypothesize that cells acquiring this cell fate are involved in scar formation after injury and studies comparing human healthy skin and scar tissue could elucidate the real impact of each FB subset on fibrotic processes. Since FBs also constitute the center of fibrotic disease etiology in other organs, this finding might have important implications beyond the skin. 1, 60 In animal studies, DPP4 + FBs have been shown to be involved in fibrotic pathologies of several other organs, and inhibition of DPP4 activity by gliptins attenuated fibrotic processes in the lung, 61 heart, 62,63 kidney, 64 and liver. 65 Therefore, our transcriptome analysis of DPP4 + FBs in the human skin might represent an important step toward the development of novel anti-fibrotic therapeutic approaches, specifically targeting the DPP4 + FB subset. However, further studies are needed to investigate whether such a FB subset with comparable contribution to fibrotic processes indeed exists in other organs in humans.
In summary, we show that dermal FBs are more heterogeneous in terms of their gene expression and function than previously expected. We therefore suggest that the old classification of dermal FBs into papillary and reticular FBs due to their anatomical location should be properly revisited, and believe that a functional classification could lead to more accurate investigations in the future. This could help decipher the exact contribution of FBs to physiological and pathological processes in the skin. In addition, we identified a specific subset of FB as the main producer of ECM in human skin. Our study has built a base for further, more detailed analyses elucidating the roles of the diverse FB populations in the healthy human skin and in fibrotic skin conditions.
